Catheter Precision, Inc. Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)
Catheter Precision, Inc. (VTAK) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2026-08-14
- Catheter Precision, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2026-06-30 was $0.00.
- Catheter Precision, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2026-03-31 was $0.00.
- Catheter Precision, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2025-12-31 was $7.81M, a 1237.84% increase year-over-year.
- Catheter Precision, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2025-09-30 was $726.00K.
- Catheter Precision, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2025 was $5.71M.
- Catheter Precision, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2024 was -$2.24M, a 131.06% decline from fiscal 2023.
- Catheter Precision, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2023 was $7.21M.
| Period end | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $7.81M derived: sum of 3 quarters · filed 2026-08-14 | $8.54M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-18 | $7.81M derived: sum of 2 quarters · filed 2026-05-18 | $8.54M derived: sum of 3 quarters · filed 2026-05-18 | $6.87M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $8.54M derived: sum of 2 quarters · filed 2026-03-31 | $6.87M derived: sum of 3 quarters · filed 2026-08-14 | $5.71M 10-K · filed 2026-03-31 |
| 2025-09-30 | $726.00K 10-Q · filed 2025-11-13 | -$941.00K derived: sum of 2 quarters · filed 2026-08-14 | -$2.10M 10-Q · filed 2025-11-13 | -$1.52M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.67M 10-Q · filed 2026-08-14 | -$2.83M 10-Q · filed 2026-08-14 | -$2.25M derived: sum of 3 quarters · filed 2026-08-14 | -$3.48M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.16M 10-Q · filed 2026-05-18 | -$579.00K derived: sum of 2 quarters · filed 2026-05-18 | -$1.81M derived: sum of 3 quarters · filed 2026-05-18 | -$3.32M derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$649.00K derived: sum of 2 quarters · filed 2026-03-31 | -$2.15M derived: sum of 3 quarters · filed 2026-03-31 | -$2.24M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$1.23M 10-Q · filed 2025-11-13 | -$2.74M derived: sum of 2 quarters · filed 2025-11-13 | -$2.82M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.50M 10-Q · filed 2025-08-11 | -$1.59M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$86.00K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $7.21M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |